50 results on '"Mitra, Vikram"'
Search Results
2. Urinary L-FABP, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease
3. Tutorial: Correction of shifts in single-stage LC-MS(/MS) data
4. Author Correction: Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis
5. Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral Sclerosis
6. Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis
7. Inversion of peak elution order prevents uniform time alignment of complex liquid-chromatography coupled to mass spectrometry datasets
8. P265 “One Stop HPB clinic” service in North East of England at a district general hospital
9. Protein expression profiles of chemo-resistant mixed phenotype liver tumors using laser microdissection and LC–MS/MS proteomics
10. Patients’ Experiences of Using Smartphone Apps to Manage their Gestational Diabetes Diagnosis: A Systematic Review - protocol (version 1)
11. A global proteomic study identifies distinct pathological features of IgG4-related and primary sclerosing cholangitis
12. Tubulin β-III: a novel immunohistochemical marker for intrahepatic peripheral cholangiocarcinoma
13. Additional file 2: of Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis
14. Additional file 1: of Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis
15. A multiomic approach to characterize the temporal sequence in Alzheimer's disease-related pathology
16. Mastering data pre-processing for accurate quantitative molecular profiling with liquid chromatography coupled to mass spectrometry
17. Interrelationship between the Levels of C9orf72 and Amyloid-β Protein Precursor and Amyloid-β in Human Cells and Brain Samples
18. Mastering van data voorverwerking voor nauwkeurige kwantitatieve moleculaire profilering met vloeistofchromatografie gekoppeld aan massaspectrometrie
19. Brain derived proteins in plasma from ALS endophenotypes
20. Isolation of aggregates containing neurofilaments from blood
21. Abstract 4966: Phospho-proteome analyses confirm the unique mode of action of MP0274, an apoptosis inducing, biparatopic HER2-targeting DARPin®drug candidate
22. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study
23. Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates
24. Identification of Analytical Factors Affecting Complex Proteomics Profiles Acquired in a Factorial Design Study with Analysis of Variance: Simultaneous Component Analysis
25. Correction to “Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer’s Disease”
26. Abstract LB-C12: Functional proteomics elucidates signaling adaptation driven by combination therapy in BRAF mutant melanoma cell line models
27. Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer’s Disease
28. A global proteomic study identifies distinct pathological features of IgG4-related and primary sclerosing cholangitis
29. O1-02-01: Microglial-derived proteins in CSF are candidate biomarkers for early diagnosis of Alzheimer's disease
30. P4-184: Comprehensive protein and pathway analysis demonstrating the effects of increasing tau toxicity in the Alzheimer's disease brain
31. O5-05-06: Discovery of multiple phosphorylated tau biomarkers in CSF using a novel mass spectrometry method
32. Low-pH Solid-Phase Amino Labeling of Complex Peptide Digests with TMTs Improves Peptide Identification Rates for Multiplexed Global Phosphopeptide Analysis
33. Abstract 1617: Quantification of pancreatic cancer proteome & phosphorylome: Indicates molecular events likely contributing to cancer & activation status of drug targets
34. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
35. Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
36. P2-105: IDENTIFYING MARKERS OF MICROGLIA ACTIVATION IN CSF FROM PATIENTS WITH ALZHEIMER'S DISEASE USING A NOVEL MASS SPECTROMETRY APPROACH
37. O3-14-04: UNRAVELLING THE ROLE OF CASEIN KINASE 1 DELTA/EPSILON INHIBITORS IN MODULATING TAU PHOSPHORYLATION AND CELL SIGNALLING PATHWAYS USING GLOBAL PHOSPHOPROTEOMICS IN A TRANSGENIC TAUOPATHY MODEL OF ALZHEIMER'S DISEASE
38. P4-255: A GLOBAL (PHOSPHO)PROTEOMIC WORKFLOW SUITABLE FOR ANALYSIS OF FRESH/FROZEN BRAIN TISSUE IN TRANSGENIC MODELS OF NEURODEGENERATION
39. P2‐097: CEREBROSPINAL FLUID PROTEOMIC BIOMARKERS ASSOCIATED WITH NORMAL AGING AND ALZHEIMER'S DISEASE
40. The safety and efficacy of transpancreatic sphincterotomy for difficult CBD cannulation during ERCP
41. Use of a novel self-expanding metal stent to allow for endoscopic drainage and necrosectomy of pancreatic fluid collections
42. Tubulin beta-3: A novel tissue diagnostic marker for intrahepatic peripheral cholangiocarcionoma.
43. Su1726 The Safety and Efficacy of Transpancreatic Sphincterotomy for Difficult CBD Cannulation During ERCP: a District General Hospital's Experience
44. Quantification of Pancreatic Cancer Proteome and Phosphorylome: Indicates Molecular Events Likely Contributing to Cancer and Activity of Drug Targets
45. Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease.
46. UNRAVELLING THE ROLE OF CASEIN KINASE 1 DELTA/EPSILON INHIBITORS IN MODULATING TAU PHOSPHORYLATION AND CELL SIGNALLING PATHWAYS USING GLOBAL PHOSPHOPROTEOMICS IN A TRANSGENIC TAUOPATHY MODEL OF ALZHEIMER'S DISEASE
47. Correction to "Glycosylation of Human Plasma Clusterin Yields a Novel Candidate Biomarker of Alzheimer's Disease".
48. Discovery of multiple phosphorylated tau biomarkers in CSF using a novel mass spectrometry method.
49. Microglial-derived proteins in CSF are candidate biomarkers for early diagnosis of Alzheimer’s disease.
50. Comprehensive protein and pathway analysis demonstrating the effects of increasing tau toxicity in the Alzheimer’s disease brain.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.